Health
Competitive multiplex binding assay can monitor SARS-CoV-2 immune responses using nanobodies – News-Medical.Net
Researchers at the Eberhard Karls University and the University of Tübingen in Germany described 11 unique nanobodies (Nbs) specific for the SARS-CoV-2 spike receptor-binding…
Measuring the presence and performance of neutralizing antibodies is crucial in the fight against the coronavirus disease 2019 (COVID-19) pandemic. This allows us to glimpse how effective vaccines and antibody therapies are in conferring protective immunity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Researchers in Germany and the U.S. described 11 unique nanobodies (Nbs) specific for the SARS-CoV-2 spike receptor-binding domain (RBD), of which 8 Nbs potentially inhibit…
-
Business24 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News24 hours agoDid AI write your accounting expert’s report? – Proctor
-
Noosa News24 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
General23 hours agoWith a deal on Australia’s environmental laws, Murray Watt has cemented his reputation as a ‘fixer’